Jefferson Davis is a biopharmaceutical entrepreneur, currently Co-Founder and Board Member at a stealth company. With an MBA from Duke University, he previously served as Chief Business Officer at Acer Therapeutics, guiding it through its acquisition by Zevra Therapeutics in 2023.
An alumnus of both Duke University and North Carolina State University, he maintains strong ties to his alma maters. His social feed indicates he actively follows and celebrates the successes of his peers and colleagues within the biopharmaceutical industry, showing a keen interest in collective progress.
He played a key executive role in the successful acquisition of Acer Therapeutics by Zevra Therapeutics.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.